Longboard Pharmaceuticals, Inc. (LBPH) Financials
LBPH Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 58.9 million | 6.8 million |
2023-06-30 | 66.2 million | 8.1 million |
2023-03-31 | 79.7 million | 7.6 million |
2022-12-31 | 70.6 million | 9.1 million |
LBPH Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -13.3 million | 856000 |
2023-06-30 | -13.5 million | 841000 |
2023-03-31 | -13.1 million | 697000 |
2022-12-31 | -9.7 million | 592000 |
LBPH Net Income
No data available :(
LBPH Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 56.0 million | - | 502000 |
2023-06-30 | 63.0 million | - | 589000 |
2023-03-31 | 76.1 million | - | 683000 |
2022-12-31 | 67.6 million | - | 740000 |
LBPH Shares Outstanding
LBPH Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 10.5 million | 3.1 million | - |
2023-06-30 | - | 12.5 million | 3.1 million | - |
2023-03-31 | - | 8.5 million | 3.4 million | - |
2022-12-31 | - | 9.2 million | 2.5 million | - |
LBPH Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 1000 |
2023-06-30 | - | 2000 |
2023-03-31 | - | 1000 |
2022-12-31 | - | 1000 |
LBPH
Price: $21.38
52 week price:
Earnings Per Share: -2.39 USD
P/E Ratio: -8.09
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 65700
Market Capitalization: 794.8 million